STABILITY INDICATING REVERSE-PHASE HIGH- PERFORMANCE LIQUID CHROMATOGRAPHY METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF TELMISARTAN AND BENIDIPINE HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORM

Authors

  • Majan Naim Department of Pharmaceutical Chemistry, Ali-Allana College of Pharmacy, Akkalkuwa, Nandurbar, Maharashtra, India.
  • Aejaz Ahmed Department of Pharmaceutical Chemistry, Ali-Allana College of Pharmacy, Akkalkuwa, Nandurbar, Maharashtra, India.
  • Khan Gj Department of Pharmacology, Ali-Allana College of Pharmacy, Akkalkuwa, Nandurbar, Maharashtra, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i5.24651

Keywords:

Telmisartan, Benidipine, Reverse-phase high- performance liquid chromatography, Stability indicating method

Abstract

 Objective: Development and validation of stability indicating reverse-phase high- performance liquid chromatography (RP-HPLC) method for simultaneous estimation of telmisartan (TEL) and benidipine hydrochloride (BND) in pharmaceutical dosage form.

Methods: Reverse phase chromatography was selected because of its suggested use for ionic and moderate to non-polar compounds. Reverse phase chromatography is simple, suitable, better regarding efficiency, stability, and reproducibility. C18 column, a 250×4.6 mm column of 5.0 μm particle packing, was selected for separation of TEL and BND. Different solvent systems were tried and optimized in combinations as mobile phase. TEL (40 μg/ml) and BND (4 μg/ml) in buffer, pH 4.0: Methanol (50:50) was developed as it was showing good peak shapes and a significant amount of resolution. The mobile phase was flowed at 1.0 ml/min with detection of both the analytes at 210 nm using photodiode array detector.

Result: Development of method was done, and validation was accomplished using specificity, linearity, accuracy, precision, robustness, limit of detection, and limit of quantitation. The method was found linear from 20 to 60 μg/ml and 2–6 μg/ml for TEL and BND individually. The percentage recoveries of TEL 100.46% and BND100.08% were, respectively.

Conclusion: This stability indicating RP-HPLC methods were developed by degradation of sample and compared with standard. The percentage relative standard deviation was also <2 % showing high degree of precision of the proposed method. The proposed method can be used for routine analysis of benidipine HCl and TEL in combined dosage form and quality control in bulk manufacturing.

Downloads

Download data is not yet available.

Author Biography

Majan Naim, Department of Pharmaceutical Chemistry, Ali-Allana College of Pharmacy, Akkalkuwa, Nandurbar, Maharashtra, India.

Pharmaceutical Quality Assurance

References

Drug profile for Telmisartan. August-2017. Available from: http:// www.drugbank.ca/drugs/DB00966. [Last accessed on 2017 Nov 20].

The Indian Pharmacopoeia Commission Ghaziabad. Indian Pharmacopoeia. Vol. III. Ghaziabad: The Indian Pharmacopoeia Commission Ghaziabad; 2010. p. 2186-7.

Drug Profile for Benidipine HCl, August-2017. Available from: http://www.drugbank.ca/drugs/DB09231. [Last accessed on 2017 Nov 20].

Drug Profile for Benidipine HCl, August-2017. Available from: https://www.aksci.com/item_detail.php?cat=K668. [Last accessed on 2017 Nov 20].

Kumar GV, Murthy TE, Rao KS. Validated RP-HPLC method for the estimation of telmisartan in serum samples. Int J Res Pharm Chem 2011;1:703-6.

Rao JS, Vijyasree V, Palavan C. A validated RP-HPLC method for the estimation of telmisartan in tablet dosage forms. Am J Pharm Tech Res 2013;3:763-9.

Rao MV, Nagendra AV, Sivanadh M, Rao GV. Validated RP-HPLC method for the estimation of telmisartan in tablet formulation. Bull Pharm Res 2012;2:50-5.

Wankhede SB, Tajane MR, Gupta KR. RP-HPLC method for simultaneous estimation of telmisartan and hydrochlorothiazide in tablet dosage form. Ind J Pharm Sci 2007;69:298-300.

Rupareliya RH, Joshi HS. Stability Indicating Simultaneous Validation of Telmisartan and Cilnidipine with Forced Degradation behavior Study by RP-HPLC in Tablet Dosage Form. London, United Kingdom: Hindawi Publishing Corporation ISRN Chromatography; 2003. p. 1-6.

Patel AR, Chandrul KK. Method development, validation and stability study for simultaneous estimation of telmisartan and indapamide by reverse phase-high performance liquid chromatography in pure and marketed formulation. Int J Pharm Bio Res 2011;2:4-16.

Jat RK, Sharma S, Chippa RC, Singh R, quantitative estimation of telmisartan in bulk drug and tablets by UV spectroscopy. Int J Drug Res Tech 2012;2:268-72.

Jaithalia R, Chauhan RK, Chauhan C, Gupta A. Development of UV spectrophotometer method and it’s validation for estimation of telmisartan as API and in pharmaceutical dosage form. Int J Res Pharm 2011;2:1816-8.

Patel K, Patel A, Dave J. Absorbance correction method for estimation of telmisartan and metoprolol succinate in combined tablet dosage forms. Pharm Methods 2012;3:106-11.

Tamboli AM, Jamadar MJ, Khan AI, Munure JY. UV-Spectrophotometric determination of telmisartan and hydrochlorothiazide in combined tablet dosage form using simultaneous equation method. Int J Adv Pharm Sci 2014;4:18-22.

Atici EB, Karliga B. Identification, synthesis and characterization of process related impurities of benidipine hydrochloride, stress-testing/stability studies and HPLC/UPLC method validations. J Pharm Anal 2015;5:265-8.

Buridi K, Shantiswarup L, Raghubabu K. Validated visible Spectrophotometric methods development for the determination of benidipine hydrochloride based on complex and internal salt formation reactions. Int J Inst Pharm Life Sci 2012;2:25-33.

Singhvi I, Chaturvedi SC. Spectrophotometric method for estimation of amlodipine basylate and benidipine HCl from tablet. Ind J Pharm Sci 1999;61:190-1.

Dong WM. Modern HPLC for Practicing Scientists. USA: A Wiley-Inter Science Publication; 2006. p. 1-9.

Krull SM. Developing and validating stability-indicating methods. LCGC North Am 2005;23:586-93.

Patel BA, Captain AD. RP-HPLC method for simultaneous estimation of telmisartan and hydrochlorothiazide in API and dosage form. Indo. Am J Pharm Res 2014;4:3031-8.

Snyder LR, Kirkland JJ, Glajch LJ. Introduction to Modern Liquid Chromatography. 2nd ed. New York, USA: A Wiley-Inter Science Publication; 1997. p. 5-42.

Patel JM, Dhingani JP, Garala KC, Raval MK. Development and validation of bioanalytical HPLC method for estimation of telmisartan in rat plasma: Application toc-pharmacokinetic studies. J Pharm Sci 2012;11:121-7.

Patel BA, Captain AD. Development and validation of RP-HPLC method for estimation of telmisartan in bulk and formulation using fluorescence detector. J Bio Med Pharm Res 2014;3:44-8.

Ruan J, Tattersall P, Lozano R, Shah P. The role of forced degradation studies in stability indicating HPLC method development. Am Pharm Rev 2006;9:46-53.

Chavhan V, Lawande R, Salunke J, Ghante M, Jagtap S. UV spectrophotometric method development and validation for telmisartan in bulk and tablet dosage form. Asian J Pharm Clin Res 2013;6:19-21.

Kumar MS, Jupally VR. Development and validation of a stability indicating Rp-Hplc method for simultaneous determination of telmisartan and amlodipine in combined dosage form. Asian J Pharm Clin Res 2014;7:32-35.

Published

01-05-2018

How to Cite

Naim, M., A. Ahmed, and K. Gj. “STABILITY INDICATING REVERSE-PHASE HIGH- PERFORMANCE LIQUID CHROMATOGRAPHY METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF TELMISARTAN AND BENIDIPINE HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORM”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 5, May 2018, pp. 342-50, doi:10.22159/ajpcr.2018.v11i5.24651.

Issue

Section

Original Article(s)